The invention provides a light therapy device for providing therapeutic treatment to a user's body, wherein the user may be a person or an animal. The device is using a light projection method for treating the body problems and/or skin disorders. Further, the device is having a rotatable assembly that automatically follows the movement of the desired area of the body needs to be treated. The device uses artificial intelligence, machine learning, localization modules, object detection module, image processing module, and 3D-mapping to automatically identify and treating the desired area of the body. Furthermore, the user can manually identify, select and prioritize desired treatment portion and can select the type of treatment required.

A phototherapy device includes at least one flexible sheet that has first and second electrical conduction layers, an electrical insulation layer between the first and second electrical conduction layers, and light emitting diodes (LEDs) disposed along the electrical insulation layer between the first and second electrical conduction layers. The first electrical conduction layer includes a conductive polymer. The electrical conduction layers and the LEDs are part of an electrical circuit in which the LEDs illuminate responsive to an electrical input. There is at least one meter to measure an electrical property of the electrical circuit. A control module is in communication with the meter and configured to adjust the electrical input responsive to the electrical property of the electrical circuit.

A phototherapy device, a kit containing such a phototherapy device, and a method for treating a patient with a phototherapy device, the phototherapy device containing a housing, an emission portion, and a light tube, the housing containing a light source that emits light at a wavelength of from about 400 nm to about 550 nm, and may contain a light shield proximal to the light source, the emission portion being distal form the housing and connected thereto via a light tube which contains an optical fibre, and a mesh that may enclose the optical fibre and may allow a limited amount of light to leak from the optical fibre to the outside environment.

A phototherapy system having sensor(s) for detecting parameters associated with light generation by a light source and circuitry for modulating the light source based on the detected parameters. Also, a phototherapy system having a light guide interfacing with a light source at a connection point, an ambient light sensor, a connector light sensor for detecting (at the connection point) ambient light received by a light emitting pad that is directed into the light guide, and circuitry for determining whether the light guide is correctly connected to the light source based on a difference between the output of the ambient light source and the connector light sensor. Further, a phototherapy system including a light emitting pad having an identification tag and circuitry that modulates a light source based on the identification tag. Additionally, a phototherapy system including a casing encapsulating multiple light emitters and a light emitting pad.

A phototherapy device includes a clothing item. Illuminators are secured to the clothing item and arranged to illuminate at least a portion of a patient wearing the clothing item. The illuminators include light emitting diodes (LEDs) mounted on at least one flexible printed circuit board (PCB). A temperature sensor is secured to the clothing item and positioned to measure a temperature proximate to the patient wearing the clothing item. A control circuit is connected to receive the temperature from the temperature sensor and operative to turn off the illuminators responsive to the temperature exceeding a maximum permitted temperature.

The current invention is disclosing a sensor to monitor changes of bilirubin blood levels. The sensor of the current invention includes a bleaching light source(s) and a sensor light source(s) and a detector(s). The invention of the disclosed sensor lies in the bleaching light source in addition to a light source that is used for optical measurement. The bleaching light source is bleaching and photocatalytic, converting bilirubin into water soluble isomers/derivatives that are faster removed from the skin and secreted by the body. As a result, deposited bilirubin is removed in the light path of the sensor light source, and the non-invasive method of the present invention is measuring the bilirubin blood level without interference from deposited bilirubin in tissue, e.g. skin. The non-invasive optical sensor and method may be applied in monitoring the progression of jaundice and to manage jaundice phototherapy.

A device for the treatment of patients by phototherapy includes a first multiple-use portion, formed of a flexible textile structure, including radiation generators formed by knitting and integrating optical fibers. At least one end of the optical fibers is connected to a light source, and the optical fibers are integrated in the knit stitches or positioned in partial wefts in the knit, to emit light due to the exceeding of their limiting bending angle, according to the so-called “macro-bending” technology. A second single-use portion, removably associated with the first portion, is intended to come into contact with the treated patient, and capable of diffusing towards the latter the light emitted by said first portion.

A ring has an open top side and side walls that circumscribe a central region for receiving a phototherapy subject. The side walls include a work surface that is configured to receive visible light through the open top side and reflect the visible light toward the central region for phototherapy. The work surface includes a first surface that is a diffuse reflector and a second surface that is a specular reflector.

A phototherapy shield for an infant includes a shield body that is sized and shaped to extend around at least a portion of a torso of an infant. The shield body includes a reflective foil layer that is sandwiched between an upper fabric layer and a lower fabric layer and that is configured to block phototherapy light. A fastener is attached to the shield body to secure the phototherapy shield around the infant's torso. The disclosed phototherapy shield and associated methods are useful for shielding an infant undergoing phototherapy, and more particularly, for shielding the chest of a premature infant undergoing phototherapy to treat jaundice. The shield body can be sized and shaped to cover the infant's chest over the second to fourth thoracic rib position to shield an area of skin above a patent ductus arteriosus (PDA).

The present invention provides a lactic acid bacterial composition for inhibiting the activity of Escherichia coli and/or treating or preventing jaundice, the composition including: a Bifidobacterium animalis subsp. lactis CP-9 strain and a Lactobacillus salivarius subsp. salicinius AP-32 strain. The present invention further provides a method for inhibiting growth of Escherichia coli, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof. The present invention additionally provides a method for treating or preventing jaundice, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof.